BATTLE-FL: A Biomarker-Integrated Study in Patients With Advanced Non-Small Cell Lung Cancer Treated in the Front-Line (FL) Setting.

Trial Profile

BATTLE-FL: A Biomarker-Integrated Study in Patients With Advanced Non-Small Cell Lung Cancer Treated in the Front-Line (FL) Setting.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Jun 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Cixutumumab (Primary) ; Pemetrexed (Primary) ; Carboplatin
  • Indications Non-small cell lung cancer
  • Focus Biomarker; Therapeutic Use
  • Acronyms BATTLE-FL
  • Most Recent Events

    • 14 Jun 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
    • 18 Oct 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
    • 16 Oct 2015 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top